TOP NEWS
Analysis
Trump's 'Abnormal' Use Of FCA Could Get Tricky In Court
By Phillip Bantz
The Trump administration is wielding the False Claims Act in unusually narrow ways to drive policies on social and cultural issues — including gender-affirming care and diversity, equity and inclusion programs — but the government's potential theories of liability under the federal law remain largely untested and might not hold up in court, experts say.
Read full article »
| Save to favorites »
POLICY & REGULATION
21 AGs Push DEA To Schedule 'Designer Xanax'
By Lauren Berg
Kentucky Attorney General Russell Coleman and 20 other state attorneys general are urgently asking the U.S. Drug Enforcement Administration to schedule an unregulated substance known as "designer Xanax" under the Controlled Substances Act, saying it is contributing to overdose deaths and posing a growing threat to public health.
Letter attached |
Read full article »
| Save to favorites »
DEALS
EXPERT ANALYSIS
LEGAL INDUSTRY
|